{
  "meta": {
    "title": "Pain_Palliative_Care",
    "url": "https://brainandscalpel.vercel.app/pain-palliative-care-6747cc5c.html",
    "scrapedAt": "2025-11-30T11:11:04.416Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Fentanyl patches ensure sustained delivery even after removal of the patch.</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Maximum plasma concentrations of fentanyl occur 5-7 h after patch application</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Up to 100 mcg/h preparations are available.</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">CYP3A4 enzyme inhibitors prolong the action of fentanyl.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Regarding transdermal fentanyl preparations, which of the following statements is incorrect?</span></p>",
      "unique_key": "DT1145087",
      "question_audio": null,
      "question_video": null,
      "map_id": 1145087,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>The maximum plasma concentration of transdermal fentanyl occurs <strong>12&ndash;24 hours</strong> after patch application, not within 5&ndash;7 hours. This delay is due to the time taken for the drug to <strong>accumulate in the stratum corneum</strong> and begin diffusing into systemic circulation.</p>\n<p>The patch creates a <strong>drug reservoir in the skin</strong>, allowing for <strong>slow and sustained release</strong>. This pharmacokinetic profile makes transdermal fentanyl suitable for <strong>chronic pain</strong>, not acute situations.</p>\n<ul>\n<li>Fentanyl patch delivers drug steadily over <strong>72 hours. </strong></li>\n<li>Peak effect begins after <strong>12&ndash;24 hours</strong></li>\n<li>A <strong>cutaneous reservoir</strong> ensures sustained delivery even after removal. <strong>(Option A ruled out)</strong></li>\n<li>Dose strengths include <strong>12, 25, 50, 75, and 100 mcg/hr </strong><strong>(Option C ruled out)</strong></li>\n<li><strong>CYP3A4</strong> is the main enzyme for fentanyl metabolism</li>\n<li><strong>Inhibitors</strong> of CYP3A4 (e.g., ketoconazole, clarithromycin) increase fentanyl levels and risk toxicity <strong>(Option D ruled out)</strong></li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Peak fentanyl levels occur <strong>12&ndash;24 hours</strong> after patch application</li>\n<li>The patch forms a <strong>skin depot</strong>, allowing <strong>continuous drug release</strong></li>\n<li><strong>CYP3A4 inhibitors</strong> increase fentanyl&rsquo;s duration and toxicity</li>\n<li>Fentanyl patches are used for <strong>chronic</strong>, not acute pain</li>\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">MIt is caused by noxious stimulation due to injury, a disease process, or the abnormal function of muscle or viscera</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">It is almost always neuropathic</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Four physiological processes are involved: transduction, transmission, modulation, and perception</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">It is associated with a systemic neuroendocrine stress response</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Regarding acute pain, all of the following statements are true except:</span></p>",
      "unique_key": "DT1160942",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160942,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer: </strong></p>\n<p>Acute pain is <strong>almost always nociceptive</strong>, not neuropathic. It results from actual or potential tissue injury that activates <strong>peripheral nociceptors</strong>. These receptors detect and transduce noxious stimuli&mdash;such as thermal, mechanical, or chemical signals&mdash;into action potentials that are then processed through the nervous system. The function of acute nociceptive pain is <strong>protective</strong>, helping localize and minimize tissue damage.</p>\n<p>Neuropathic pain, in contrast, arises from <strong>direct injury or dysfunction of the nervous system</strong> and is more common in chronic pain syndromes, not typical in acute presentations.<strong>(Option A ruled out)</strong></p>\n<ul>\n<li><strong>Nociceptive pain</strong> is the most common mechanism of <strong>acute pain</strong></li>\n<li>Neuropathic pain may occur in <strong>chronic pain</strong>, or in specific acute conditions like nerve injury, but is <strong>not the usual mechanism</strong></li>\n<li>The four key processes in nociceptive pain are <strong>transduction</strong>, <strong>transmission</strong>, <strong>modulation</strong>, and <strong>perception(Option C ruled out)</strong></li>\n<li>Acute pain triggers a <strong>systemic neuroendocrine stress response</strong>, involving catecholamines and cortisol release<strong>(Option D ruled out)</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250707f45d2099-c730-4dda-9842-c57b68d92ed0.png\">\n <p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Acute pain is <strong>primarily nociceptive</strong>, not neuropathic</li>\n<li>Neuropathic pain is more common in <strong>chronic pain conditions</strong></li>\n<li>Involves <strong>transduction, transmission, modulation, and perception</strong></li>\n<li>Associated with <strong>neuroendocrine stress response</strong> (&uarr; catecholamines and cortisol)</li>\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-a, 3-d, 4-c</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-b, 3-c, 4-d</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-d, 3-a, 4-b</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-c, 3-b, 4-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following terms related to sensory perception and pain with their correct descriptions:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507077300a28a-a1ff-43cb-947a-5b89c324134e.png\"></span></p>",
      "unique_key": "DT1160956",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160956,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Allodynia - b.</strong> Perception of an ordinarily nonnoxious stimulus as pain<br /> Example: A light touch feeling painful, such as brushing hair causing sharp pain.</p>\n<p><strong>Analgesia - a.</strong> Absence of pain perception<br /> Example: A patient does not feel pain even during a normally painful stimulus.</p>\n<p><strong>Anesthesia - d.</strong> Absence of all sensation<br /> Example: A region of the body feels neither pain, temperature, touch, nor vibration.</p>\n<p><strong>Dysesthesia - c.</strong> Unpleasant or abnormal sensation with or without a stimulus<br /> Example: Burning or electric shock sensations without actual external stimuli.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507071eeb23ca-a35f-474f-a72c-cbc1c074b9d6.png\">",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2 weeks</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">3-4 weeks</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">3 months</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">At what time frame following the postsurgical period does persistent postsurgical pain become defined as \"Chronic pain\"?</span></p>",
      "unique_key": "DT1160958",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160958,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<ul>\n<li>Chronic postsurgical pain is defined as <strong>pain that persists for at least 3 months following a surgical procedure or tissue injury</strong>, beyond the expected time for normal healing.</li>\n<li>According to the <strong>International Association for the Study of Pain (IASP)</strong>, this pain may either <strong>develop after the procedure</strong> or <strong>increase in intensity postoperatively</strong> and must not be attributable to other causes such as infection or recurrent disease.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>1&ndash;2 weeks</strong> (<strong>Option A</strong>): This duration falls under the <strong>acute postoperative pain phase</strong>. Pain during this time is considered part of the normal healing process.</p>\n<p><strong>3&ndash;4 weeks</strong> (<strong>Option B</strong>): While healing may be incomplete in some cases at 3&ndash;4 weeks, pain at this stage is still usually considered <strong>subacute</strong>, not chronic.</p>\n<p><strong>6 months</strong> (<strong>Option D</strong>): Although some definitions use 6 months for general chronic pain, the <strong>IASP specifically defines chronic postsurgical pain</strong> as pain lasting <strong>at least 3 months</strong>, making 6 months too late for the clinical threshold.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Chronic postsurgical pain = pain lasting <strong>&ge;3 months</strong> post-surgery</li>\n<li>Must not be due to other causes like <strong>infection or recurrence</strong></li>\n<li>Defined by <strong>IASP</strong> and widely used in clinical pain management</li>\n</ul>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Numerical rating scale</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Wong-Baker FACES rating scale</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">McGill Pain Questionnaire</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Visual analogue scale</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You ask a patient of chronic pain in the pain clinic, to mark his pain severity on a 10-cm horizontal line labeled \"no pain\" at one end and \"worst pain imaginable\" on the other end. Which scale of pain measurement are you using here?</span></p>",
      "unique_key": "DT1160967",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160967,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation :</strong></p>\n<p>Asking a patient to <strong>mark a point on a 10-cm horizontal line</strong> labeled from \"no pain\" to \"worst pain imaginable\" is characteristic of the <strong>Visual Analogue Scale (VAS)</strong>. The <strong>VAS is a continuous scale</strong> used to assess <strong>pain intensity</strong>, especially in chronic pain settings. The <strong>distance (in cm or mm)</strong> from the left end to the patient&rsquo;s mark quantifies the <strong>severity of the pain</strong> numerically without pre-defined categories.</p>\n<ul>\n<li>VAS is especially useful in tracking pain <strong>over time</strong> or <strong>before and after treatment</strong></li>\n<li>It provides a <strong>simple and reproducible</strong> measurement</li>\n<li>Requires the patient to <strong>self-assess</strong> their pain without verbal or numerical input</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250707c918f660-303d-4545-8908-9989cef7a22b.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Numerical rating scale</strong> (<strong>Option A</strong>): Patients are asked to <strong>rate their pain on a scale of 0&ndash;10</strong>, where 0 is no pain and 10 is the worst imaginable pain. It uses <strong>explicit numbers</strong> and does not involve marking a line.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507079bd2820c-e3b5-4bde-b8f1-cb5de77d87db.png\">\n<p><strong>Wong-Baker FACES rating scale</strong> (<strong>Option B</strong>): Primarily used in <strong>children aged 3 years and above</strong> or patients with communication difficulties. The patient selects from a series of <strong>facial expressions</strong>, ranging from smiling (no pain) to crying (worst pain), to indicate their pain.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507073884032d-a672-4a3b-96c6-f365beb4a3a3.png\">\n<p><strong>McGill Pain Questionnaire</strong> (<strong>Option C</strong>): A <strong>qualitative and multidimensional</strong> assessment tool. It includes a <strong>checklist of descriptive words</strong> that reflect the <strong>sensory, affective, and evaluative</strong> components of pain, providing insights into the <strong>nature and quality</strong> of pain, not just its intensity.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>VAS uses a <strong>10-cm line</strong> for patients to <strong>mark pain severity visually</strong></li>\n<li>Best suited for <strong>quantifying pain intensity</strong> in <strong>chronic pain settings</strong></li>\n<li>Distinct from <strong>numerical</strong>, <strong>faces</strong>, and <strong>word-based multidimensional tools</strong></li>\n</ul>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-depressants</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuroleptics</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-convulsant</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-emetics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following groups of drugs can be used in the pharmacological management of chronic pain except:</span></p>",
      "unique_key": "DT1160969",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160969,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<ul>\n<li><strong>Anti-emetic drugs</strong> are primarily used to <strong>prevent or treat nausea and vomiting</strong> and have <strong>no established role in the direct pharmacological management of chronic pain</strong>.</li>\n<li>They do not possess analgesic properties and are not included in standard chronic pain treatment protocols.</li>\n</ul>\n<p>Pharmacological interventions for pain manage include the use of the following groups of drugs:</p>\n<ul>\n<li>Acetaminophen</li>\n<li>Non steroidal anti inflammatory drugs</li>\n<li>Antidepressants</li>\n<li>Neuroleptics</li>\n<li>Antispasmodics and muscle relaxants</li>\n<li>Corticosteroids</li>\n<li>Anti-convulsant</li>\n<li>Local anaesthetics</li>\n<li>Alpha-2 Adrenergic agonists</li>\n<li>Opioids</li>\n<li>Botulinum toxin</li>\n</ul>\n<p>Anti-emetic drugs are not known to have any analgesic action.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Anti-depressants</strong> (<strong>Option A</strong>): Used effectively in <strong>neuropathic pain</strong>, especially tricyclic antidepressants (TCAs) and SNRIs. They inhibit serotonin and norepinephrine reuptake, enhancing <strong>descending inhibitory pain pathways</strong>.</p>\n<p><strong>Neuroleptics</strong> (<strong>Option B</strong>): Certain neuroleptics may have a role in <strong>complex cancer pain</strong>, especially where there's a component of <strong>agitation, delirium, or nausea</strong>, although their <strong>primary use is psychiatric</strong>.</p>\n<p><strong>Anti-convulsant</strong> (<strong>Option C</strong>): Drugs like <strong>gabapentin and pregabalin</strong> are first-line agents in <strong>neuropathic pain</strong>. They decrease <strong>neuronal excitability</strong> and central sensitization.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Anti-emetics are <strong>not part of standard pain management</strong> protocols</li>\n<li>Chronic pain treatment includes <strong>antidepressants, anticonvulsants, neuroleptics, NSAIDs, opioids, and local agents</strong></li>\n<li><strong>Neuropathic pain</strong> requires adjuvant drugs like <strong>anticonvulsants and antidepressants</strong></li>\n</ul>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">7</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">8</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">11</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old child operated for a hernia repair surgery, in the postoperative period, is moaning, reaching the wound, has a painful expression on the face, wants to see its mother, is shivering and kicking his legs. What is the CHEOPS score for this patient?</span></p>",
      "unique_key": "DT1160974",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160974,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation :</strong></p>\n<p>The CHEOPS (Children&rsquo;s Hospital of Eastern Ontario Pain Scale) is a behavioral pain assessment tool used in children aged 1 to 7 years, particularly in the postoperative period. It evaluates six behavioral domains. In this 4-year-old child:</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507072e2f14bc-65fd-4ac8-9733-87e9622f40d3.png\">\n<p>Moaning - Verbal = 2</p>\n<p>Reaching the wound - Touch = 2</p>\n<p>Painful facial expression - Facial = 2</p>\n<p>Wants mother (verbal comfort seeking) - Verbal (additional) = 1</p>\n<p>Shivering torso - Torso = 2</p>\n<p>Kicking legs - Legs = 2</p>\n<p>Cry (assumed crying or moaning) - Cry = 2</p>\n<p>Total score = 2 (Cry) + 2 (Facial) + 3 (Verbal) + 2 (Torso) + 2 (Touch) + 2 (Legs) = 11</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>CHEOPS scale</strong> is used for <strong>postoperative pain assessment</strong> in <strong>children aged 1-7 years</strong></li>\n<li>Total score range: <strong>4 (no pain)</strong> to <strong>13 (severe pain)</strong></li>\n<li>Considers <strong>verbal, motor, and facial indicators</strong></li>\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduction in functional residual capacity</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Atelectasias</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoxemia</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased tidal volume due to pain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old patient undergoes a midline laparotomy for intestinal obstruction. All of the following respiratory effects can be seen in the post-operative period in this patient, except:</span></p>",
      "unique_key": "DT1160977",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160977,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation&nbsp;:<br /> </strong>Postoperative pain, particularly following <strong>abdominal or thoracic surgeries</strong>, leads to <strong>splinting</strong> or <strong>guarding behavior</strong> where the patient subconsciously reduces chest wall and diaphragmatic movement to minimize pain. This results in a <strong>decreased tidal volume</strong>, not an increase. Pain-induced limitation of respiratory effort compromises <strong>ventilation</strong>, <strong>oxygenation</strong>, and <strong>airway clearance</strong>, predisposing the patient to <strong>pulmonary complications</strong>.</p>\n<ul>\n<li>Pain: <strong>decreases chest wall movement</strong></li>\n<li>Leads to: reduced<strong> tidal volume</strong> and <strong>functional residual capacity (FRC)</strong>(<strong>Option A ruled out</strong>)</li>\n<li>Promotes <strong>atelectasis</strong> and <strong>V/Q mismatch</strong>, contributing to <strong>hypoxemia</strong> (<strong>Option B and C ruled out</strong>)</li>\n<li>Also impairs <strong>effective coughing</strong>, increasing risk of <strong>mucous plugging and infection</strong></li>\n</ul>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">L2-L3</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">L3-L4</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">L4-L5</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">L5-S1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old male presents to his primary care physician's office with a major complaint of back pain radiating into the gluteal region and pain in the distribution of the plantar surface of the foot on the same side. The patient's physical examination reveals decreased plantar flexion of the foot. An MRI will most commonly show a herniated disk at</span></p>",
      "unique_key": "DT1160980",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160980,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>The patient presents with <strong>radiating back pain into the gluteal region</strong> and <strong>pain over the plantar surface of the foot</strong>, accompanied by <strong>weakness in plantar flexion</strong>. These findings are <strong>hallmark features of S1 nerve root involvement</strong>, which is most commonly affected by a <strong>herniated disk at the L5-S1 level</strong>.</p>\n<p>Disk herniation at L5-S1 leads to:</p>\n<ul>\n<li>Pain in the <strong>gluteal area</strong>, <strong>posterior thigh</strong>, <strong>posterolateral calf</strong>, and <strong>plantar foot</strong>, especially between the <strong>fourth and fifth toes</strong></li>\n<li>Weakness of <strong>plantar flexion</strong> (gastrocnemius and soleus muscles)</li>\n<li>Loss or reduction of the <strong>ankle jerk reflex</strong></li>\n</ul>\n<p>This pattern of symptoms perfectly fits the <strong>S1 radiculopathy</strong>, confirming L5-S1 as the involved disk level.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250707af1a2380-931f-4acc-8bd4-8a4f41f7ee37.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>L2-L3</strong> (<strong>Option A</strong>): This would involve the <strong>L3 nerve root</strong>, causing anterior thigh pain and <strong>no involvement of the foot or gluteal region</strong>. Not compatible with this patient's symptoms.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>L5-S1 disk herniation</strong> affects <strong>S1 nerve root</strong></li>\n<li>Leads to pain in <strong>gluteal region, posterior thigh, posterolateral calf, and plantar foot</strong></li>\n<li>Associated with <strong>plantar flexion weakness</strong> and <strong>loss of ankle reflex</strong></li>\n<li>Most common site of <strong>lumbar disk herniation</strong></li>\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Adaptive</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Spontaneous</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">With changes in pain pathways</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the pain clinic, neuropathic pain can be differentiated from nociceptive pain by all of the following features except:</span></p>",
      "unique_key": "DT1160985",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160985,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:<br /> Neuropathic pain</strong> arises from <strong>direct injury or dysfunction of the nervous system</strong> and is considered <strong>maladaptive</strong>, meaning it no longer serves a protective or beneficial role. Instead of aiding recovery or healing (as nociceptive pain does), neuropathic pain <strong>persists abnormally</strong>, often in the absence of ongoing tissue damage. It may be <strong>spontaneous</strong>, chronic, and associated with <strong>abnormal processing in the pain pathways</strong>, such as peripheral sensitization and central plasticity.</p>\n<p>In contrast, <strong>nociceptive pain</strong> is <strong>adaptive-</strong>it is a normal response to noxious stimuli, guiding behavior to <strong>protect against further tissue injury</strong> or to promote healing.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507071ace0c63-684d-48cd-b01e-fd92af9773e4.png\">\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Neuropathic pain</strong> is <strong>maladaptive</strong>, often <strong>spontaneous, chronic</strong>, and involves <strong>altered pain pathways</strong></li>\n<li><strong>Nociceptive pain</strong> is <strong>adaptive</strong>, protective, and tied to identifiable tissue damage</li>\n<li>Neuropathic pain does <strong>not require a stimulus</strong>, and often features <strong>allodynia or hyperalgesia</strong></li>\n</ul>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension and tachycardia</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased work of breathing</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary retention</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased peristalsis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A trauma patient presenting with acute pain can be expected to have all of the following systemic responses to pain except:</span></p>",
      "unique_key": "DT1160991",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160991,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation :</strong></p>\n<ul>\n<li>Acute pain, especially in trauma, activates the sympathetic nervous system, triggering widespread systemic effects.</li>\n<li>One of the gastrointestinal consequences is a decrease in peristalsis due to reduced parasympathetic and increased sympathetic tone.</li>\n<li>This leads to ileus rather than increased motility. Thus, \"increased peristalsis\" is the incorrect choice.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hypertension and tachycardia</strong> (<strong>Option A</strong>): Acute pain leads to <strong>release of catecholamines</strong> (epinephrine, norepinephrine), increasing <strong>heart rate</strong>, <strong>blood pressure</strong>, and <strong>myocardial workload</strong>. This is a classic stress response.</p>\n<p><strong>Increased work of breathing</strong> (<strong>Option B</strong>): Due to <strong>increased metabolic demand</strong>, patients often <strong>hyperventilate</strong>, which increases <strong>minute ventilation</strong> and respiratory muscle workload. Pain involving the chest or abdomen also causes <strong>splinting</strong>, further contributing to shallow and inefficient breathing.</p>\n<p><strong>Urinary retention</strong> (<strong>Option C</strong>): Sympathetic activation causes <strong>detrusor relaxation and internal sphincter contraction</strong>, inhibiting micturition and promoting <strong>urinary retention</strong>, especially after trauma or surgery.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Acute pain causes <strong>sympathetic activation</strong>: Increased HR, BP, respiratory rate; reduced GI motility</li>\n<li><strong>Decreased peristalsis</strong>, not increased, is typical: leads to <strong>ileus</strong></li>\n<li>Also causes <strong>urinary retention</strong> and <strong>increased respiratory workload</strong></li>\n<li>Pain control is crucial to mitigate these systemic stress effects</li>\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Balloon compression of the otic ganglion</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycerol injection</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Microvascular decompression of the trigeminal nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 43-year-old female presents to the pain clinic with electric shock like pain on the right side of the face. All of the following are treatment options except</span></p>",
      "unique_key": "DT1160994",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160994,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation :</strong><br /> The patient presents with <strong>electric shock-like facial pain</strong>, a classic feature of <strong>trigeminal neuralgia</strong>. The most common cause is <strong>compression of the trigeminal nerve root (CN V)</strong>, often by the <strong>superior cerebellar artery</strong>.</p>\n<p>Balloon compression of the <strong>otic ganglion</strong> is <strong>not</strong> a treatment for trigeminal neuralgia. The otic ganglion is a <strong>parasympathetic ganglion associated with the glossopharyngeal nerve (CN IX)</strong> and has <strong>no role in the pathophysiology or management of trigeminal neuralgia</strong>, which involves the <strong>trigeminal (CN V) nerve</strong>.</p>\n<p>Management of trigeminal neuralgia includes <strong>medical therapy</strong> and <strong>interventional procedures</strong>.</p>\n<ul>\n<li><strong>Carbamazepine</strong> is the <strong>drug of choice</strong>, offering excellent initial symptom control.(<strong>Option A ruled out</strong>)</li>\n<li>When medication fails or is not tolerated, <strong>interventional options</strong> include:\n<ul>\n<li><strong>Glycerol injection</strong>(<strong>Option C ruled out</strong>)</li>\n<li><strong>Radiofrequency ablation</strong></li>\n<li><strong>Balloon compression of the Gasserian (trigeminal) ganglion</strong></li>\n<li><strong>Microvascular decompression</strong> (definitive, if vascular conflict exists) (<strong>Option D ruled out</strong>)</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Trigeminal neuralgia</strong> presents with <strong>electric shock-like unilateral facial pain</strong>, often triggered by light touch, chewing, or speaking</li>\n<li><strong>Carbamazepine</strong> is the <strong>first-line drug</strong></li>\n<li>Invasive treatments include <strong>glycerol injection, balloon compression of the gasserian ganglion</strong>, and <strong>microvascular decompression</strong></li>\n<li><strong>Otic ganglion is unrelated</strong> to trigeminal pain and is <strong>not a treatment target</strong></li>\n</ul>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Phantom pain</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Complex regional pain syndrome</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic visceral pelvic pain</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Compartment syndrome pain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Chronic pain indications for insertion of a spinal cord stimulator include all of the following, except</span></p>",
      "unique_key": "DT1160997",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160997,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong><br /> Compartment syndrome pain is not an indication for spinal cord stimulator (SCS) placement. This type of pain is acute, ischemic, and requires emergent fasciotomy to relieve pressure and restore perfusion. Using neuromodulation techniques like SCS in this scenario would delay definitive management and risk permanent damage.</p>\n<p>SCS is primarily indicated for chronic neuropathic pain syndromes, especially when pain is refractory to pharmacologic and conservative measures.</p>\n<p><strong>Spinal Cord Stimulation (SCS): </strong>Involves placing electrodes in the <strong>epidural space</strong> to deliver electrical impulses that modulate pain signals.</p>\n<p><strong>Indications for Spinal Cord Stimulator (SCS) Placement</strong> for chronic pain typically include:</p>\n<ul>\n<li><strong>Phantom pain</strong>.(<strong>Option A ruled out</strong>)</li>\n<li><strong>Complex Regional Pain Syndrome (CRPS)</strong>.(<strong>Option B ruled out</strong>)</li>\n<li><strong>Chronic visceral pelvic pain</strong> (in select, refractory cases, especially with neuropathic features). (<strong>Option C ruled out</strong>)</li>\n<li>Other chronic neuropathic pain conditions (e.g., failed back surgery syndrome, peripheral neuropathies).</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>SCS is indicated for chronic, refractory neuropathic pain</strong>\n<ul>\n<li>Examples: <strong>CRPS, phantom limb pain, peripheral neuropathy, ischemic limb pain, chronic pelvic pain</strong></li>\n</ul>\n</li>\n<li><strong>Compartment syndrome</strong> is a <strong>surgical emergency</strong>, not managed with neuromodulation</li>\n<li>Neuromodulation is <strong>contraindicated in acute ischemic or compressive conditions</strong></li>\n</ul>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Herniated disk</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Amputation</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuropathic pain</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic neuropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following clinical diagnoses best describes deafferentation pain?</span></p>",
      "unique_key": "DT1160999",
      "question_audio": null,
      "question_video": null,
      "map_id": 1160999,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<ul>\n<li>Deafferentation pain occurs when there is a loss of sensory input from the periphery to the central nervous system, leading to central disinhibition and abnormal pain processing.</li>\n<li>The classic clinical condition representing this is <strong>phantom limb</strong> pain after amputation, where pain is perceived in a body part that no longer exists, due to loss of afferent sensory signals and reorganization of central pain pathways.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Herniated disk</strong> (<strong>Option A</strong>): Causes <strong>compressive radiculopathy</strong> with nerve root irritation but not complete deafferentation. Sensory input may be altered, but not entirely lost.</p>\n<p><strong>Neuropathic pain</strong> (<strong>Option C</strong>): A broad term encompassing pain from nerve injury or dysfunction, including but not limited to deafferentation. It is a <strong>category</strong>, not a specific clinical condition.</p>\n<p><strong>Diabetic neuropathy</strong> (<strong>Option D</strong>): A form of <strong>chronic peripheral neuropathy</strong>, usually affecting small fibers. It involves <strong>dysfunctional</strong>, not absent, sensory input, so it does not qualify as deafferentation.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Deafferentation pain</strong> = pain due to <strong>loss of sensory input</strong> to CNS</li>\n<li><strong>Amputation</strong> is the prototypical example that leads to <strong>phantom limb pain</strong></li>\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic hip pain is a better example of neuropathic pain than this condition</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Narcotics are the most effective and first-line treatment option</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">It is most optimally treated with multimodal therapies</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Spinal cord stimulator has no proven benefit in such cases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old man presents with persistent burning pain and hypersensitivity over the left chest wall 2 months after recovering from a vesicular rash in the same region. The pain is described as sharp, shooting, and worsens with light touch or clothing contact. Which of the following statements best reflects the nature and optimal management of his condition?</span></p>",
      "unique_key": "DT1161002",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161002,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation :</strong></p>\n<p>The patient's presentation (persistent burning, sharp, shooting pain, hypersensitivity, allodynia, following a vesicular rash) is a classic description of <strong>postherpetic neuralgia (PHN)</strong>, a prototypical <strong>neuropathic pain</strong> condition. Neuropathic pain arises from a lesion or disease of the somatosensory system. The optimal approach for managing such complex pain is <strong>multimodal therapy</strong>, which targets various pain pathways and mechanisms.</p>\n<ul>\n<li><strong>Neuropathic pain</strong> is characterized by symptoms like burning, shooting, electric-like sensations, often accompanied by allodynia (pain from non-noxious stimuli) and hyperalgesia (increased response to noxious stimuli).</li>\n<li><strong>Optimal treatment for neuropathic pain is multimodal</strong>, combining different therapeutic approaches to address its complex nature.</li>\n<li>First-line pharmacological treatments include <strong>anticonvulsants</strong> (gabapentin, pregabalin) and <strong>antidepressants</strong>(TCAs, SNRIs like amitriptyline, duloxetine).</li>\n<li><strong>Topical agents</strong> (lidocaine, capsaicin) are also considered.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Chronic hip pain is a better example of neuropathic pain than this condition (Option A):</strong> <strong>This statement is incorrect.</strong> Chronic hip pain is typically <strong>nociceptive</strong> (e.g., from joint degeneration or inflammation), whereas the described condition (postherpetic neuralgia) is a classic and definitive example of <strong>neuropathic pain</strong>.</p>\n<p><strong>Narcotics are the most effective and first-line treatment option (Option B):</strong> <strong>This statement is incorrect.Narcotics (opioids) are not considered first-line treatment for neuropathic pain</strong> due to risks of tolerance, dependence, and limited long-term efficacy. They are typically reserved for refractory cases.</p>\n<p><strong>Spinal cord stimulator has no proven benefit in such cases (Option D):</strong> <strong>This statement is incorrect.Spinal cord stimulators are effective</strong> in chronic, resistant neuropathic conditions like PHN and Complex Regional Pain Syndrome (CRPS), and may be considered as an interventional option in refractory cases.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Neuropathic pain</strong>, such as postherpetic neuralgia, is best managed with a <strong>multimodal therapy approach</strong>, combining various first-line pharmacological agents (anticonvulsants, antidepressants, topical agents) and, in refractory cases, interventional options like spinal cord stimulation. Opioids are generally not first-line</p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-opioid analgesics</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Weak oral opioids</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Strong opioids</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-convulsant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The World Health Organization recommends a progressive, three-step approach for management of cancer pain by oral analgesics. All of the following are its components except:</span></p>",
      "unique_key": "DT1161005",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161005,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>The WHO analgesic ladder is a well-established, three-step protocol for the oral management of cancer pain, particularly in palliative care. It involves a stepwise escalation of analgesic strength based on pain severity. <strong>Anti-convulsants, while useful as adjuvant drugs</strong> in certain pain syndromes (especially neuropathic pain), <strong>are not a core component </strong>of the WHO's original three-step ladder.</p>\n<p>The three steps are:</p>\n<ul>\n<li>Step 1: Non-opioid analgesics (e.g., acetaminophen, NSAIDs) for mild pain(<strong>Option A ruled out</strong>)</li>\n<li>Step 2: Weak opioids (e.g., codeine, tramadol) &plusmn; non-opioids for moderate pain (<strong>Option B ruled out</strong>)</li>\n<li>Step 3: Strong opioids (e.g., morphine, fentanyl) &plusmn; non-opioids for severe pain(<strong>Option C ruled out</strong>)</li>\n</ul>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">A 1, B 4, C 2, D 3</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">A 3, B 2, C 4, D 1</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">A 3, B 4, C 2, D 1</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">A 1, B 2, C 4, D 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following parts of the transdermal patch with the correct label:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507070f8a069c-1976-4e6d-b477-051aa5e24ecb.png\"></span></p>",
      "unique_key": "DT1161009",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161009,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507072a92f488-ce85-4f34-910a-3e38d0f3be54.png\">\n<ul>\n<li><strong>Backing film</strong>: Outer protective layer</li>\n<li><strong>Drug-containing layer</strong>: Holds the active drug, releases through membrane</li>\n<li><strong>Rate-controlling membrane</strong>: Regulates drug delivery rate</li>\n<li><strong>Skin adhesive layer</strong>: Keeps patch in place and may also contain drug in some systems</li>\n</ul>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Migraine</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Trigeminal neuralgia</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Cluster headache</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension headache</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient in the pain clinic complains of tight, band-like pain in the bilateral frontal region. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1161012",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161012,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Tension-type headache typically presents with a <strong>bilateral, tight or squeezing sensation</strong>, often described as a <strong>band-like pressure</strong> around the forehead or scalp.</li>\n<li>The discomfort is usually mild to moderate in intensity and<strong> lacks the pulsatile quality </strong>seen in migraines.</li>\n<li>This type of headache is <strong>not worsened by physical activity</strong> and is not associated with <strong>nausea, vomiting, or significant photophobia.</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:<br /> Migraine (Option A):</strong> Presents with <strong>unilateral, throbbing pain</strong> that can be moderate to severe and is often associated with <strong>nausea, vomiting, and sensitivity to light and sound</strong>. It may be preceded by an aura and is aggravated by physical activity.</p>\n<p><strong>Trigeminal neuralgia (Option B):</strong> Characterized by <strong>sudden, electric shock&ndash;like pain</strong> in the distribution of the trigeminal nerve, typically <strong>unilateral</strong> and in the V2 or V3 dermatome. The pain is brief, intense, and triggered by minor stimuli like brushing teeth or touching the face.</p>\n<p><strong>Cluster headache (Option C):</strong> Known for its <strong>severe, unilateral, periorbital pain</strong>, often described as burning or stabbing. It is frequently associated with <strong>autonomic symptoms</strong> such as lacrimation, rhinorrhea, and ptosis. It tends to occur in cyclical patterns, often waking the patient from sleep.</p>\n<p><strong>Key Takeaway:<br /> </strong>Tension-type headache is distinguished by its <strong>bilateral distribution, steady \"band-like\" pressure</strong>, and <strong>absence of systemic symptoms</strong>, making it the most likely diagnosis in this patient.</p>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Postural hypotension and light headedness</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Constipation and urinary retention</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Vena cava and aortic vascular injury</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Retroperitoneal hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are about to perform a celiac plexus block in a patient. When obtaining informed consent, which of the following is not a typical complication to disclose?</span></p>",
      "unique_key": "DT1161014",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161014,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>Celiac plexus block interrupts sympathetic innervation to the abdominal organs. This unopposes the parasympathetic nervous system, often resulting in<strong> increased gastrointestinal motility and diarrhea, not constipation. </strong>Similarly, <strong>urinary retention is not typically caused</strong> by this block. Therefore, constipation and urinary retention are not expected complications and need not be routinely disclosed in consent, making this the correct answer.</p>\n<p>A celiac plexus block is indicated for patients with pain arising from the abdominal viscera, particularly intra-abdominal cancers.</p>\n<p>Complications involved while performing the block include:</p>\n<ul>\n<li>Postural hypotension from block of visceral sympathetic innervation is the most common complication<strong>(Option A ruled out)</strong></li>\n<li>Accidental intravascular injection into the vena cava or aorta</li>\n<li>Injury of the vena cava or aorta <strong>(Option C ruled out)</strong></li>\n<li>Pneumothorax</li>\n<li>Retroperitoneal hemorrhage <strong>(Option D ruled out)</strong></li>\n<li>Sexual dysfunction</li>\n<li>Injury to the kidneys or pancreas</li>\n<li>Rarely, paraplegia (due to spasm of, or injury to, the lumbar artery of Adamkiewicz)</li>\n<li>Blocking the sympathetic chain may result in relatively unopposed parasympathetic activity that may lead to increased gastrointestinal motility and diarrhea.</li>\n</ul>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Lumbosacral strain</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Myofascial syndromes</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibromyalgia syndrome</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Degenerative disk disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Common causes for lower back pain include all of the following, except</span></p>",
      "unique_key": "DT1161015",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161015,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong><br /> Fibromyalgia is a <strong>central pain syndrome</strong> characterized by <strong>widespread musculoskeletal pain</strong>, fatigue, and sleep disturbances. It is not typically localized to the <strong>lower back</strong> and does <strong>not represent a primary or common cause</strong> of isolated lower back pain.</p>\n<p><strong>Explanation of Other Options:<br /> Lumbosacral strain (Option A):</strong> This is one of the most frequent causes of acute and chronic lower back pain. It involves overstretching or tearing of muscles or ligaments in the lumbosacral region, usually following physical activity, improper posture, or lifting.</p>\n<p><strong>Myofascial syndromes (Option B):</strong> This refers to regional pain due to <strong>trigger points in the muscles or fascia</strong>, commonly affecting the back. Myofascial pain is a <strong>well-recognized contributor</strong> to chronic lower back discomfort.</p>\n<p><strong>Degenerative disk disease (Option D):</strong> A very common cause of chronic lower back pain, especially with aging. It involves <strong>breakdown of intervertebral disks</strong>, leading to reduced disk height, instability, and inflammation of adjacent structures.</p>\n<p><strong>Key Takeaway:</strong> <br /> Common causes of lower back pain include structural and mechanical issues like <strong>lumbosacral strain</strong>, <strong>myofascial pain</strong>, and <strong>degenerative disk disease</strong>, but <strong>fibromyalgia</strong> causes <strong>generalized</strong> rather than localized pain and is <strong>not a common cause</strong> of isolated lower back pain.</p>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Complex regional pain syndrome</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Phantom limb pain</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-herpetic neuralgia</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute pain due to pelvic exenteration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Types of pain disorders that are commonly treated using \"sympathetic blockade\" include all of the following, except</span></p>",
      "unique_key": "DT1161019",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161019,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>Acute pain following <strong>pelvic exenteration</strong>, although severe, is primarily <strong>somatic and visceral</strong> in nature and not typically mediated by the <strong>sympathetic nervous system</strong>.</p>\n<p>Hence, it <strong>does not respond well to sympathetic blockade</strong>, which is more suited for <strong>chronic sympathetically maintained pain</strong>. Therefore, this option is correctly excluded.</p>\n<p><strong>Sympathetic blockade</strong> is primarily indicated in pain conditions that are <strong>sympathetically maintained</strong>, especially those with chronic neuropathic features. Typical indications include:</p>\n<ul>\n<li><strong>Complex Regional Pain Syndrome (CRPS)</strong> &ndash; Stellate ganglion or lumbar sympathetic blocks are frequently used.<strong>(Option A ruled out)</strong></li>\n<li><strong>Phantom Limb Pain</strong> &ndash; Especially in early stages, when there is a sympathetically mediated component.<strong>(Option B ruled out)</strong></li>\n<li><strong>Post-Herpetic Neuralgia (PHN)</strong> &ndash; May respond variably to sympathetic blockade, particularly in chronic cases.<strong>(Option C ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Second-order wide dynamic range neurons</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Dorsal horn neuron</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Spinal cord reflexes</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Activation of which of the following mechanisms and/or pathways best describes \"central sensitization\" at the level of the spinal cord?</span></p>",
      "unique_key": "DT1161023",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161023,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>Central sensitization refers to the <strong>increased responsiveness of nociceptive neurons in the central nervous system</strong> to their normal or subthreshold input. It occurs at the level of the <strong>spinal cord dorsal horn</strong> and involves multiple overlapping mechanisms. These include:</p>\n<ol>\n<li><strong>Second-order wide dynamic range neurons:</strong> These neurons integrate input from both nociceptive and non-nociceptive afferents. Their increased excitability is a hallmark of central sensitization, leading to <strong>allodynia and hyperalgesia</strong>.<strong>(Option A ruled out)</strong></li>\n<li><strong>Dorsal horn neurons:</strong> Central sensitization primarily occurs here. Persistent nociceptive input can lead to <strong>long-term potentiation-like changes</strong>, receptor upregulation (e.g., NMDA), and altered neurotransmitter release, leading to heightened pain perception. <strong>(Option B ruled out)</strong></li>\n<li><strong>Spinal cord reflexes (like flexion withdrawal reflex):</strong> These become <strong>exaggerated</strong> in central sensitization due to increased excitability of interneuronal circuits, further contributing to chronic pain behaviors.<strong>(Option C ruled out)</strong></li>\n</ol>\n<p>All these mechanisms are interconnected and cumulatively contribute to the development and persistence of central sensitization. Hence, <strong>Option D is correct.</strong></p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Central sensitization</strong> is a complex process involving <strong>multiple spinal mechanisms</strong>&mdash;including enhanced activity of <strong>wide dynamic range neurons</strong>, <strong>increased excitability of dorsal horn neurons</strong>, and <strong>augmented spinal reflexes</strong>&mdash;all contributing to chronic pain.</p>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">It is also known as neurogenic inflammation</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">It is associated with Lewi's triple response</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">It is decreased by injection of local anesthetics</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">It is increased by application of capsaicin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Incorrect statement regarding secondary hyperalgesia is</span></p>",
      "unique_key": "DT1161026",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161026,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>Increased sensitivity following application of capsaicin does not occur; instead, capsaicin leads to desensitization. It <strong>decreases</strong> secondary hyperalgesia by <strong>depleting substance P</strong> from nociceptive C fibers and <strong>desensitizing TRPV1 receptors</strong> on sensory neurons. Therefore, secondary hyperalgesia is diminished, not increased, by capsaicin.</p>\n<ul>\n<li>Neurogenic inflammation, also called secondary hyperalgesia, plays an important role in peripheral sensitization following injury.<strong>(Option A ruled out)</strong></li>\n<li>Secondary hyperalgesia&nbsp;<strong>is manifested by the triple response of Lewis</strong> (<strong>option B ruled out</strong>): a red flush around the site of injury (flare), local tissue edema, and sensitization to noxious stimuli.</li>\n<li>It is diminished by injection of a local anesthetic.(<strong>option C ruled out</strong>)</li>\n<li><strong>Capsaicin</strong> applied topically in a gel, cream, or patch depletes substance P, <strong>diminishes neurogenic inflammation,</strong> and is useful for some patients with post-herpetic neuralgia.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Neurogenic inflammation, also called secondary hyperalgesia, is diminished by injection of a local anesthetic</li>\n<li><strong>Lewis' triple response</strong> is a physical manifestation of neurogenic inflammation.</li>\n<li><strong>Capsaicin</strong> reduces hyperalgesia through TRPV1 receptor desensitization and <strong>substance P depletion</strong>.</li>\n</ul>",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Facial nerve</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Trigeminal nerve</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Glossopharyngeal nerve</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Vagal nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are administering Gasserian ganglion block in a patient with neuralgia. Gasserian ganglion block is most commonly used for neuropathic pain located in which of the following nerve distributions?</span></p>",
      "unique_key": "DT1161029",
      "question_audio": null,
      "question_video": null,
      "map_id": 1161029,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation for answer:</strong></p>\n<p>The <strong>gasserian ganglion block</strong> is primarily used to treat <strong>neuropathic pain</strong> in the distribution of the <strong>trigeminal nerve</strong>, especially in cases such as <strong>trigeminal neuralgia</strong> or intractable cancer-related facial pain. The ganglion contains the sensory cell bodies of the trigeminal nerves three major divisions&mdash;<strong>ophthalmic (V1), maxillary (V2), and mandibular (V3)</strong>&mdash;making it an ideal target for managing <strong>facial pain syndromes</strong>.</p>\n<ul>\n<li>The <strong>gasserian (or trigeminal) ganglion</strong> is located in <strong>Meckel&rsquo;s cave</strong> and houses the <strong>sensory neurons</strong> of the trigeminal nerve.</li>\n<li><strong>Trigeminal neuralgia</strong>, often described as an &ldquo;electric shock&ndash;like&rdquo; pain over the face, is a classic indication for <strong>gasserian ganglion block</strong>, especially in patients who are refractory to medications like carbamazepine.</li>\n<li>The procedure can involve <strong>radiofrequency ablation</strong>, chemical neurolysis, or injection of local anesthetic with steroid depending on indication and chronicity.</li>\n<li>This block may also be considered in <strong>oncologic pain</strong> involving structures innervated by V2 or V3.</li>\n<li>Complications may include <strong>corneal anesthesia</strong>, <strong>dysesthesia</strong>, and rarely <strong>intracranial hemorrhage</strong> or <strong>hypesthesia</strong> in adjacent cranial nerves.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250707d1bc5f94-a351-4d06-a8b4-10a430fb44f1.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Facial nerve</strong> (<strong>option A</strong>): The <strong>facial nerve (cranial nerve VII)</strong> primarily controls <strong>motor function</strong> to the muscles of facial expression. It carries only limited sensory input (taste from the anterior two-thirds of the tongue and skin over the external ear). It is <strong>not involved</strong> in the sensory innervation of the face and is <strong>not a target for gasserian ganglion block</strong>.</p>\n<p><strong>Glossopharyngeal nerve</strong> (<strong>option C</strong>): The <strong>glossopharyngeal nerve (cranial nerve IX)</strong> carries sensation from the <strong>posterior third of the tongue</strong>, <strong>pharynx</strong>, and <strong>middle ear</strong>. It may be targeted in glossopharyngeal neuralgia, but this involves a <strong>glossopharyngeal nerve block</strong>, not the gasserian ganglion.</p>\n<p><strong>Vagal nerve</strong> (<strong>option D</strong>): The <strong>vagus nerve (cranial nerve X)</strong> innervates thoracic and abdominal viscera and provides <strong>parasympathetic control</strong>. It is unrelated to <strong>facial pain syndromes</strong> and is not associated with the gasserian ganglion.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>Gasserian ganglion block</strong> is indicated in <strong>trigeminal neuralgia</strong>, especially when refractory to medications.</p>\n<p>It targets the <strong>sensory root of cranial nerve V</strong>, affecting <strong>V1&ndash;V3 divisions</strong> depending on the clinical presentation.</p>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Nalbuphine 5 mg intravenous (IV)</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexmedetomidine 30 &mu;g IV</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Diphenhydramine 50 mg IV</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Propofol 10 mg IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following techniques is LEAST effective in the treatment of pruritus from administration of neuraxial opiates?</span></p>",
      "unique_key": "DT1227565",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227565,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Dexmedetomidine does not directly treat pruritus caused by neuraxial opioids. Although it may reduce opioid requirements and thereby potentially reduce the <strong>incidence</strong>, it does not alleviate <strong>established pruritus</strong>, which is why it is considered the least effective among the listed options.</p>\n<ul>\n<li>Neuraxial opioid-induced pruritus is primarily <strong>&mu;-opioid receptor mediated</strong>, not due to histamine release.</li>\n<li><strong>Nalbuphine</strong> and other <strong>mixed opioid agonist-antagonists</strong> provide relief by <strong>displacing &mu;-opioid receptor activity</strong> without fully reversing analgesia<strong>.(Option A ruled out)</strong></li>\n<li><strong>Diphenhydramine</strong> works <strong>via sedation;</strong> Has has antihistamine properties. <strong>(Option c ruled out)</strong></li>\n<li><strong>Propofol</strong> at low doses reduces pruritus via <strong>central GABAergic effects</strong>.<strong>(Option D ruled out)</strong></li>\n</ul>",
      "correct_choice_id": 242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">0.05 mg</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">0.1 mg</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">1 mg</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Morphine should not be injected into the intrathecal space</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An analgesic effect similar to the epidural administration of 2.5 mg of morphine could be achieved by which dose of intrathecal morphine?</span></p>",
      "unique_key": "DT1227566",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227566,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Morphine is a <strong>hydrophilic opioid</strong>, which allows it to stay longer in the cerebrospinal fluid and act on spinal opioid receptors. It is <strong>safe and effective</strong> both <strong>epidurally</strong> and <strong>intrathecally</strong>, but the required doses vary significantly. <strong>(Option D ruled out)</strong></p>\n<p>Intrathecal morphine is significantly more potent than epidural morphine due to <strong>direct deposition into the cerebrospinal fluid</strong>, bypassing barriers such as fat sequestration and dural penetration. An epidural dose of 2.5 mg morphine is approximately equivalent to <strong>0.1 mg intrathecal morphine</strong>, given the 10&ndash;25 times higher potency of intrathecal administration.</p>\n<ul>\n<li><strong>Site of action</strong> for neuraxial opioids is the <strong>substantia gelatinosa (Rexed lamina II)</strong> in the dorsal horn of the spinal cord.</li>\n<li><strong>Intrathecal opioids</strong> act directly at the spinal cord with <strong>smaller required doses</strong> and <strong>faster onset</strong>.</li>\n<li><strong>Morphine is hydrophilic</strong>, leading to <strong>slower onset</strong> and <strong>longer duration</strong> (up to 24 hours), but higher risk of <strong>delayed respiratory depression</strong>.</li>\n<li><strong>Epidural morphine dose</strong>: 1&ndash;5 mg<br /> <strong>Intrathecal morphine equivalent</strong>: 0.1&ndash;0.3 mg <strong>(Options A &amp; C ruled out)</strong></li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>0.1 mg intrathecal morphine</strong> provides analgesia comparable to <strong>2.5 mg epidural morphine</strong>, due to <strong>direct action in the CSF</strong> and <strong>increased potency</strong>.</p>\n<p>Proper dosing is critical to balance analgesia with risk of <strong>delayed respiratory depression</strong>, particularly with <strong>hydrophilic agents</strong> like morphine.</p>",
      "correct_choice_id": 252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral amitriptyline</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral clonidine</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Topical capsaicin ointment</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Topical lidocaine patch</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 95-year-old woman has persistent and prolonged thoracic pain after a herpes zoster infection. Which of the treatments below would be the LEAST efficacious in the treatment of her pain?</span></p>",
      "unique_key": "DT1227567",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227567,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation for answer:</strong></p>\n<p>Oral clonidine has not demonstrated reliable analgesic efficacy in treating <strong>postherpetic neuralgia (PHN)</strong>, especially in elderly patients with established, persistent pain. While clonidine may have theoretical benefits due to its central &alpha;2-agonist effects, <strong>it is not considered an evidence-based treatment</strong> for PHN, making it the least effective among the listed options.</p>\n<p><strong>Postherpetic neuralgia (PHN):</strong></p>\n<ul>\n<li><strong>PHN</strong> is chronic neuropathic pain that <strong>persists &gt;3 months after resolution of herpes zoster rash</strong>.</li>\n<li>It is more common in patients <strong>over 50</strong>, particularly those with <strong>severe initial pain</strong> or <strong>extensive rash</strong>.</li>\n<li>Effective treatments include\n<ul>\n<li><strong>Tricyclic antidepressants</strong> (e.g., amitriptyline)<strong>(Option A ruled out)</strong></li>\n<li><strong>Anticonvulsants</strong></li>\n<li>T<strong>opical lidocaine </strong><strong>(Option D ruled out)</strong></li>\n<li><strong>Topical capsaicin</strong><strong>(Option B ruled out)</strong></li>\n<li><strong>Opioids</strong></li>\n</ul>\n</li>\n<li><strong>Sympathetic blocks</strong> are useful <strong>early in the disease</strong>, not in chronic PHN.</li>\n<li><strong>Clonidine</strong>, although a central &alpha;2 agonist, <strong>lacks consistent efficacy in PHN</strong>.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>Oral clonidine</strong> is not an evidence-based treatment for <strong>postherpetic neuralgia</strong> and is considered <strong>least efficacious</strong> among listed therapies.</p>\n<p>For <strong>elderly patients with PHN</strong>, use <strong>TCAs</strong>, <strong>topical lidocaine</strong>, <strong>capsaicin</strong>, or <strong>gabapentinoids</strong> as first-line treatments.</p>",
      "correct_choice_id": 262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Etiology</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronicity</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Type of symptoms</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Rapidity of onset</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Complex regional pain syndrome (CRPS) type I (reflex sympathetic dystrophy [RSD]) is differentiated from CRPS type II (causalgia) by knowledge of its</span></p>",
      "unique_key": "DT1227568",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227568,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250707ec959a06-c54c-4a61-a034-fabd098d0305.png\">\n<p><strong>Explanation:</strong></p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Chronicity</strong> <strong>(Option B)</strong>: Both types of CRPS can become <strong>chronic</strong> if not diagnosed and treated early. Chronic progression is not a reliable differentiator.</p>\n<p><strong>Type of symptoms</strong> <strong>(Option C)</strong>: The <strong>symptoms in both CRPS I and II are nearly identical</strong>, including pain, vasomotor, and sensory abnormalities.</p>\n<p><strong>Rapidity of onset (Option D)</strong>: The <strong>onset may vary in both types</strong> depending on individual and injury context, but this does not differentiate the subtypes.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>CRPS type I</strong> and <strong>CRPS type II</strong> share similar clinical features, but <strong>etiology</strong>&mdash;specifically the <strong>presence of nerve injury</strong>&mdash;is the key factor that differentiates them.</p>\n<p>Early recognition and <strong>multimodal pain management</strong> are essential to prevent chronic disability.</p>",
      "correct_choice_id": 271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">The incidence of phantom limb pain increases with more distal amputations</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Most amputees do not experience phantom limb pain</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Nerve blocks may be used to decrease the incidence of phantom limb pain</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Traumatic amputees have a much higher incidence of phantom limb pain than nontraumatic amputees</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Select the one TRUE statement concerning phantom limb pain.</span></p>",
      "unique_key": "DT1227569",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227569,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation for answer:</strong></p>\n<p><strong>Nerve blocks administered in the perioperative period</strong> have shown benefit in reducing the <strong>incidence and severity of phantom limb pain</strong>. By providing regional anesthesia during and after amputation, these blocks may <strong>prevent central sensitization</strong> and reduce the development of chronic pain pathways, making them a valuable preventive strategy.</p>\n<p>Phantom Limb Pain:</p>\n<p><strong>Definition:</strong> Phantom limb pain is a persistent pain perceived in the missing part of a limb after amputation.</p>\n<p><strong>Incidence:</strong> It occurs in <strong>up to 80% of amputees</strong>. It can begin immediately or days after amputation.</p>\n<p><strong>Risk Factors:</strong></p>\n<ul>\n<li><strong>More proximal amputations</strong> are associated with a <strong>higher incidence</strong> of phantom limb pain, likely due to greater nerve and tissue disruption. (<strong>Option A</strong> <strong>ruled out)</strong></li>\n<li>The incidence is <strong>similar between traumatic and nontraumatic amputees</strong>. (<strong>Option D</strong> <strong>ruled out)</strong></li>\n</ul>\n<p><strong>Pathophysiology:</strong> It is believed to result from <strong>cortical reorganization, central sensitization, and nerve injury</strong>.</p>\n<p><strong>Management:</strong></p>\n<ul>\n<li><strong>Effective modalities</strong> include regional nerve blocks, gabapentinoids, TCAs, opioids, TENS (Transcutaneous Electrical Nerve Stimulation), and spinal cord stimulation.</li>\n<li><strong>Nerve blocks</strong> may be used as a treatment.</li>\n</ul>\n<p><strong>Preventive Measures:</strong></p>\n<ul>\n<li><strong>Perioperative nerve blocks</strong> are clinically important in surgical planning as they can help prevent phantom limb pain by attenuating central sensitization. (<strong>Option C</strong> <strong>ruled out)</strong></li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>Perioperative nerve blocks</strong> can help <strong>prevent phantom limb pain</strong> by attenuating central sensitization.</p>\n<p><strong>Proximal amputations</strong> are more likely to cause phantom limb pain, and its occurrence is <strong>common</strong>, not rare, in amputees.</p>",
      "correct_choice_id": 283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">T4</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">T10</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">L3</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">S1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 75-year-old man is scheduled to undergo elective orchiectomy for prostate cancer. The patient has selected spinal anesthesia. What is the minimum dermatomal level that must be achieved to carry out this operation?</span></p>",
      "unique_key": "DT1227571",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227571,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The testes derive their visceral afferent innervation from spinal segments T10&ndash;T11, following the embryological descent from the abdomen. Therefore, spinal anesthesia for orchiectomy must at least reach T10 to ensure pain-free manipulation.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>T4 (Option A)</strong>: This is the dermatome for the <strong>nipple line</strong>, typically needed for <strong>upper abdominal or thoracic surgeries</strong>, not scrotal or testicular procedures.</p>\n<p><strong>L3</strong> <strong>(Option C)</strong>:&nbsp; This corresponds to <strong>mid-thigh sensory innervation</strong>, which is <strong>below</strong> the required level for orchiectomy. It would not block the <strong>visceral afferents of the testes</strong>.</p>\n<p><strong>S1</strong> <strong>(Option D)</strong>:&nbsp; This supplies the <strong>posterior leg and foot</strong>, and is <strong>far too low</strong> for surgeries involving <strong>pelvic or abdominal viscera</strong> like the testes.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>T10 dermatome block</strong> is the <strong>minimum required level</strong> for spinal anesthesia in testicular surgery due to the <strong>visceral innervation of the testes</strong>.</p>\n<p>Always align <strong>sensory block level</strong> with the <strong>embryological origin and innervation</strong> of the target organ to ensure effective anesthesia.</p>",
      "correct_choice_id": 292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">T1-T4</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">T5-T8</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">T9-T12</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">L1-L4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The artery of Adamkiewicz MOST frequently arises from the aorta at which spinal level?</span></p>",
      "unique_key": "DT1227572",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227572,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>The artery of Adamkiewicz&nbsp; artery most commonly originates from a left posterior intercostal artery between <strong>T9 and T12</strong>.</p>\n<ul>\n<li><strong>Anatomy:</strong>\n<ul>\n<li>The artery of Adamkiewicz, also known as the great anterior segmental medullary artery, is a crucial blood supply to the spinal cord.</li>\n<li>It most commonly arises from a left posterior intercostal artery between <strong>T9 and T12</strong>.</li>\n<li>It plays a critical role in reinforcing the anterior spinal artery, which supplies the anterior two-thirds of the spinal cord.</li>\n<li>It is the <strong>main blood supply for the lower thoracic, lumbar, and sacral cord segments</strong>.</li>\n</ul>\n</li>\n<li><strong>Clinical Significance:</strong>\n<ul>\n<li>Damage or occlusion of the artery of Adamkiewicz can result in <strong>anterior spinal cord syndrome and paraplegia</strong>.</li>\n<li>This artery is at risk of injury during surgical or endovascular procedures near the thoracoabdominal aorta (e.g., aortic aneurysm repair).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p>The <strong>artery of Adamkiewicz</strong> most frequently arises at <strong>T9&ndash;T12</strong>, reinforcing the anterior spinal artery and supplying the <strong>lower spinal cord</strong>.</p>\n<p>Injury to this artery can lead to <strong>anterior spinal artery syndrome</strong> and <strong>paraplegia</strong>, especially during <strong>aortic surgeries</strong>.</p>",
      "correct_choice_id": 303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32,
      "choices": [
        {
          "id": 311,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterus</span></p>"
        },
        {
          "id": 312,
          "text": "<p><span style=\"font-size:12.0pt;\">Stomach</span></p>"
        },
        {
          "id": 313,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreas</span></p>"
        },
        {
          "id": 314,
          "text": "<p><span style=\"font-size:12.0pt;\">Gallbladder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A celiac plexus block would not effectively treat pain resulting from a malignancy involving which of the following organs?</span></p>",
      "unique_key": "DT1227573",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227573,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>The <strong>uterus is a pelvic organ</strong>, and its pain innervation is primarily through the <strong>hypogastric plexus</strong>, not the celiac plexus. Therefore, a celiac plexus block would <strong>not effectively treat pain</strong> resulting from a malignancy involving the uterus, as the nerve pathways responsible for transmitting uterine pain signals do not pass through the celiac plexus.</p>\n<ul>\n<li>The <strong>celiac plexus</strong> is a complex network of nerves located in the abdomen, anterior to the aorta at the level of T12-L1. It provides sympathetic and, to a lesser extent, parasympathetic innervation to most of the <strong>upper abdominal viscera</strong>.</li>\n<li>These organs include the lower esophagus, stomach, duodenum, jejunum, ileum, large intestine (up to the splenic flexure), pancreas, liver, biliary tract (gallbladder and bile ducts), spleen, kidneys, adrenal glands, and omentum.</li>\n<li><strong>Pain from malignancies</strong> of these upper abdominal organs<strong> (like stomach, pancreas, and gallbladder)</strong> is often effectively managed with a celiac plexus block. <strong>(Options B, C &amp; D ruled out)</strong></li>\n<li><strong>Pelvic organs</strong> such as the <strong>uterus</strong>, ovaries, prostate, bladder, rectum, and distal colon receive their main innervation from the <strong>hypogastric plexus</strong> (superior and inferior hypogastric plexuses).</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p>A <strong>celiac plexus block</strong> is effective for pain originating from <strong>upper abdominal organs</strong> due to their innervation by the celiac plexus. However, it is <strong>not effective for pain from pelvic organs</strong> like the <strong>uterus</strong>, which are primarily innervated by the <strong>hypogastric plexus</strong>.</p>",
      "correct_choice_id": 311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33,
      "choices": [
        {
          "id": 321,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct electrical inhibition of type A-&delta; and C fibers</span></p>"
        },
        {
          "id": 322,
          "text": "<p><span style=\"font-size:12.0pt;\">Depletion of neurotransmitter in nociceptors</span></p>"
        },
        {
          "id": 323,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperpolarization of spinothalamic tract neurons</span></p>"
        },
        {
          "id": 324,
          "text": "<p><span style=\"font-size:12.0pt;\">Activation of inhibitory neurons</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The mechanism of low-frequency transcutaneous electrical nerve stimulation (TENS) units in relieving pain is</span></p>",
      "unique_key": "DT1227574",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227574,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>The mechanism of low-frequency transcutaneous electrical nerve stimulation (TENS) in relieving pain primarily involves the <strong>activation of inhibitory neurons</strong>, leading to the release of endogenous opioids.</p>\n<ul>\n<li>Transcutaneous Electrical Nerve Stimulation (TENS) is a non-invasive pain relief technique that uses mild electrical currents delivered through electrodes placed on the skin. It is used to alleviate both acute and chronic pain.</li>\n<li><strong>Types of TENS and their mechanisms:</strong> TENS typically operates in two main frequency ranges with distinct mechanisms:</li>\n<li><strong>Low-frequency TENS (2-10 Hz):</strong>\n<ul>\n<li>Primarily works via the <strong>opioid system</strong>.</li>\n<li>It stimulates the release of <strong>endogenous endorphins/opioids</strong>.</li>\n<li>These endorphins then <strong>activate inhibitory neurons</strong> in the central nervous system, particularly at the spinal cord level.</li>\n<li>The analgesic effect is <strong>naloxone-reversible</strong>, confirming opioid involvement.</li>\n<li>This mechanism aligns with the descending pain inhibitory pathways in the brainstem and spinal cord.</li>\n</ul>\n</li>\n<li><strong>High-frequency TENS (&gt;50 Hz):</strong>\n<ul>\n<li>Thought to primarily work via the <strong>gate control theory of pain</strong>, by activating large afferent A&beta; fibers.</li>\n<li>This activation inhibits pain transmission at the spinal cord dorsal horn.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p>Low-frequency TENS alleviates pain primarily by <strong>activating inhibitory neurons</strong> through the release of <strong>endogenous endorphins</strong>, leading to the modulation of pain signals in the spinal cord and brain.</p>",
      "correct_choice_id": 324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34,
      "choices": [
        {
          "id": 331,
          "text": "<p><span style=\"font-size:12.0pt;\">Sufentanil</span></p>"
        },
        {
          "id": 332,
          "text": "<p><span style=\"font-size:12.0pt;\">Fentanyl</span></p>"
        },
        {
          "id": 333,
          "text": "<p><span style=\"font-size:12.0pt;\">Morphine sulfate</span></p>"
        },
        {
          "id": 334,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydromorphone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Epidural use of which of the following opioids would result in the greatest incidence of delayed respiratory depression?</span></p>",
      "unique_key": "DT1227575",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227575,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>Epidural use of <strong>morphine sulfate</strong> results in the <strong>greatest incidence of delayed respiratory depression</strong> because of its <strong>high hydrophilicity (water solubility)</strong>. After epidural administration, morphine tends to remain in the cerebrospinal fluid (CSF) for a prolonged period. This allows for significant <strong>cephalad (upward) migration</strong> within the spinal canal to reach the brainstem's respiratory centers, leading to a delayed onset of potentially severe respiratory depression, typically occurring several hours after administration.</p>\n<ul>\n<li><strong>Lipid solubility</strong> of an opioid is the primary determinant of its <strong>onset, duration, and the risk profile for side effects</strong> when administered epidurally or intrathecally.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250707b6446d72-d57e-4c4c-ad32-2475d83c99de.png\">",
      "correct_choice_id": 333,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35,
      "choices": [
        {
          "id": 341,
          "text": "<p><span style=\"font-size:12.0pt;\">C5</span></p>"
        },
        {
          "id": 342,
          "text": "<p><span style=\"font-size:12.0pt;\">C6</span></p>"
        },
        {
          "id": 343,
          "text": "<p><span style=\"font-size:12.0pt;\">C7</span></p>"
        },
        {
          "id": 344,
          "text": "<p><span style=\"font-size:12.0pt;\">C8</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21-year-old patient reports tingling in her thumb during her cesarean section under epidural anesthesia. To which dermatomal level would this correspond?</span></p>",
      "unique_key": "DT1227576",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227576,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The sensation of tingling in the <strong>thumb</strong> specifically corresponds to the <strong>C6 dermatome</strong>. This dermatome covers the lateral forearm and thumb, and a tingling sensation here indicates that the epidural anesthetic is affecting this spinal nerve root level.</p>\n<ul>\n<li><strong>Dermatomes</strong> are areas of skin mainly supplied by afferent nerve fibers from a single dorsal root of any spinal nerve.</li>\n<li>Key upper limb dermatomes to remember:\n<ul>\n<li><strong>C5:</strong> Lateral arm (shoulder to elbow).<strong>(Option A ruled out)</strong></li>\n<li><strong>C6:</strong> <strong>Thumb</strong> and lateral forearm.</li>\n<li><strong>C7:</strong> Middle finger.<strong>(Option C ruled out)</strong></li>\n<li><strong>C8:</strong> Ring and little fingers, and medial forearm.<strong>(Option D ruled out)</strong></li>\n<li><strong>T1:</strong> Medial arm.</li>\n</ul>\n</li>\n<li>For Cesarean section, a block up to the <strong>T4 dermatome</strong> (nipple line) is generally desired for adequate surgical anesthesia and patient comfort.</li>\n</ul>",
      "correct_choice_id": 342,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 36,
      "choices": [
        {
          "id": 351,
          "text": "<p><span style=\"font-size:12.0pt;\">Younger adults</span></p>"
        },
        {
          "id": 352,
          "text": "<p><span style=\"font-size:12.0pt;\">Early ambulation</span></p>"
        },
        {
          "id": 353,
          "text": "<p><span style=\"font-size:12.0pt;\">Pregnancy</span></p>"
        },
        {
          "id": 354,
          "text": "<p><span style=\"font-size:12.0pt;\">Large needle size</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Each of the following is associated with an increased incidence of PDPHs except</span></p>",
      "unique_key": "DT1227577",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227577,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:<br /> Early ambulation</strong> has <strong>NOT been consistently shown to increase the incidence of post-dural puncture headache (PDPH)</strong>.The primary cause of PDPH is cerebrospinal fluid (CSF) leakage through the dural hole, which is influenced more by factors like needle size, type, and patient characteristics rather than immediate post-puncture activity.&nbsp;</p>\n<p><strong>Post-Dural Puncture Headache (PDPH):</strong></p>\n<ul>\n<li>PDPH is caused by continuous <strong>CSF leakage</strong> through the dural rent, leading to intracranial hypotension.</li>\n<li><strong>Risk factors for increased incidence of PDPH:</strong>\n<ul>\n<li><strong>Younger age</strong> (especially 18-40 years) due to more elastic dura.<strong>(Option A ruled out)</strong></li>\n<li><strong>Female sex</strong> (higher incidence than men).</li>\n<li><strong>Pregnancy</strong> (significantly higher incidence than non-pregnant women, potentially due to hormonal factors, increased abdominal pressure, and venous engorgement).<strong>(Option C ruled out)</strong></li>\n<li><strong>Larger needle gauge</strong> (bigger dural hole -&gt; more CSF leakage).<strong> (Option D ruled out)</strong></li>\n<li><strong>Cutting-point needles</strong> (e.g., Quincke) compared to non-cutting/pencil-point needles (e.g., Whitacre, Sprotte).</li>\n<li><strong>Transverse orientation</strong> of the needle bevel during dural puncture (cutting more dural fibers) versus longitudinal orientation (splitting fibers).</li>\n<li><strong>Multiple dural puncture attempts</strong>.</li>\n<li>History of <strong>previous PDPH</strong>.</li>\n</ul>\n</li>\n<li><strong>Factors NOT consistently shown to increase PDPH risk:</strong>\n<ul>\n<li><strong>Timing of ambulation</strong> (early vs. delayed).</li>\n<li><strong>Patient position</strong> (supine vs. sitting) immediately after puncture.</li>\n</ul>\n</li>\n<li><strong>Management of PDPH:</strong>\n<ul>\n<li><strong>Conservative:</strong> Hydration, caffeine, analgesics, rest.</li>\n<li><strong>Definitive:</strong> <strong>Epidural blood patch (EBP)</strong> &ndash; considered the gold standard for severe or persistent PDPH.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>PDPH incidence is increased by factors that promote CSF leakage or are inherent patient predispositions</strong> (e.g., <strong>younger age, female sex, pregnancy, larger/cutting needles</strong>).</li>\n<li><strong>Early ambulation does NOT increase the risk of PDPH</strong>, despite previous beliefs.</li>\n<li>The <strong>epidural blood patch (EBP)</strong> is the definitive treatment for severe PDPH.</li>\n</ul>",
      "correct_choice_id": 352,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37,
      "choices": [
        {
          "id": 361,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain is transmitted via the vagus nerve</span></p>"
        },
        {
          "id": 362,
          "text": "<p><span style=\"font-size:12.0pt;\">The nerve fibers are type C</span></p>"
        },
        {
          "id": 363,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain is characterized by a dull aching or burning sensation</span></p>"
        },
        {
          "id": 364,
          "text": "<p><span style=\"font-size:12.0pt;\">Distention of the transverse colon causes more pain than surgical transection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Each of the following items describes pain in the abdominal viscera EXCEPT</span></p>",
      "unique_key": "DT1227578",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227578,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>Pain arising from the abdominal viscera is <strong>NOT primarily transmitted via the vagus nerve</strong>. While the vagus nerve (cranial nerve X) does contain a large number of afferent fibers, these are mainly involved in conveying non-painful physiological information (e.g., stretch, chemical changes, visceral reflexes). Instead, <strong>visceral pain signals</strong> from the abdomen are predominantly transmitted by <strong>sympathetic afferent nerve fibers</strong> that accompany sympathetic efferent nerves to the spinal cord.</p>\n<ul>\n<li><strong>Visceral Pain Characteristics:</strong>\n<ul>\n<li><strong>Diffuse, poorly localized</strong>, and often referred to somatic structures (e.g., shoulder pain from diaphragmatic irritation).</li>\n<li>Described as <strong>dull, aching, burning, cramping, or gnawing</strong>.<strong>(Option C ruled out)</strong></li>\n<li>Caused by <strong>stretch, distention, ischemia, inflammation, or spasm</strong> of hollow viscera.</li>\n<li><strong>NOT typically caused by cutting or crushing</strong> of solid organs/viscera (as pain receptors are scarce in their parenchyma).</li>\n</ul>\n</li>\n<li><strong>Visceral Pain Transmission:</strong>\n<ul>\n<li>Primarily via <strong>unmyelinated C fibers</strong> (slow conduction, dull pain).<strong>(Option B ruled out)</strong></li>\n<li>These <strong>afferent fibers travel with sympathetic nerves</strong> to the spinal cord.</li>\n<li>The <strong>vagus nerve</strong> carries visceral afferents, but these are generally involved in <strong>non-painful physiological monitoring</strong> (e.g., satiety, gut distension for reflexes), not direct pain transmission.</li>\n</ul>\n</li>\n<li><strong>Mechanism of Visceral Pain:</strong>\n<ul>\n<li><strong>Distention of a hollow viscus</strong> (e.g., bowel obstruction) is a potent painful stimulus because it excites diffuse nociceptive nerve endings over a large area.<strong>(Option D ruled out) </strong></li>\n<li><strong>Surgical transection</strong> of the gut or parenchyma of solid organs causes surprisingly little pain because pain receptors are sparse and the stimulus is highly localized.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Abdominal visceral pain is transmitted by sympathetic afferent C fibers</strong>, leading to diffuse, dull, aching sensations.</li>\n<li><strong>Distention of hollow organs is a strong pain stimulus</strong>, while cutting solid viscera causes minimal pain.</li>\n<li>The <strong>vagus nerve does NOT primarily transmit pain signals</strong> from the abdominal viscera; its afferents are mainly involved in non-painful physiological monitoring.</li>\n</ul>",
      "correct_choice_id": 361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38,
      "choices": [
        {
          "id": 371,
          "text": "<p><span style=\"font-size:12.0pt;\">A-alpha (A&alpha;)</span></p>"
        },
        {
          "id": 372,
          "text": "<p><span style=\"font-size:12.0pt;\">A-beta (A&beta;)</span></p>"
        },
        {
          "id": 373,
          "text": "<p><span style=\"font-size:12.0pt;\">A-delta (A&delta;)</span></p>"
        },
        {
          "id": 374,
          "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In addition to C nerve fibers, which nerve fibers carry pain impulses?</span></p>",
      "unique_key": "DT1227580",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227580,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>In addition to C nerve fibers, <strong>A-delta (A&delta;) nerve fibers</strong> also carry pain impulses. A-delta fibers are <strong>myelinated</strong>, smaller in diameter than A&alpha; or A&beta; fibers, and conduct impulses at a medium velocity. They are responsible for transmitting the sensation of <strong>initial, sharp, well-localized pain</strong>, often referred to as \"first pain.\" This distinct type of pain contrasts with the duller, more diffuse \"second pain\" primarily carried by the slower, unmyelinated C fibers.</p>\n<ul>\n<li><strong>Nerve fiber classification</strong> is based on diameter, myelination, and conduction velocity, which correlate with their functions.</li>\n<li><strong>Pain-transmitting fibers:</strong>\n<ul>\n<li><strong>A-delta (A&delta;) fibers:</strong>\n<ul>\n<li><strong>Myelinated</strong></li>\n<li><strong>Medium conduction velocity</strong> (5-25 m/sec)</li>\n<li>Responsible for <strong>sharp, localized, \"first pain\"</strong> and temperature sensation.</li>\n</ul>\n</li>\n<li><strong>C fibers:</strong>\n<ul>\n<li><strong>Unmyelinated</strong></li>\n<li><strong>Slow conduction velocity</strong> (0.1-2 m/sec)</li>\n<li>Responsible for <strong>dull, aching, burning, poorly localized, \"second pain\"</strong> and temperature/touch.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Non-pain transmitting fibers (relevant for distinction):</strong>\n<ul>\n<li><strong>A-alpha (A&alpha;) fibers:</strong> Largest, myelinated. Primarily <strong>motor (efferent) to skeletal muscles</strong> and proprioception.<strong>(Option A ruled out)</strong></li>\n<li><strong>A-beta (A&beta;) fibers:</strong> Large, myelinated. Primarily transmit <strong>touch, pressure, and proprioception</strong> (non-nociceptive sensory). These are important in the <strong>Gate Control Theory of Pain</strong>, where their activation can inhibit pain transmission.<strong>(Option B ruled out)</strong></li>\n<li><strong>A-gamma (A&gamma;) fibers:</strong> Motor fibers to muscle spindles (muscle tone).</li>\n<li><strong>B fibers:</strong> Myelinated, smaller. <strong>Preganglionic autonomic</strong> fibers (sympathetic and parasympathetic).<strong> (Option D ruled out)</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Pain impulses are carried by two main types of nerve fibers: A-delta (A&delta;) for sharp, \"first\" pain and C fibers for dull, \"second\" pain.</li>\n<li>The distinction lies in their <strong>myelination status</strong> (A&delta; are myelinated, C are unmyelinated) and resulting <strong>conduction velocity</strong> and <strong>pain quality</strong>.</li>\n</ul>",
      "correct_choice_id": 373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 39,
      "choices": [
        {
          "id": 381,
          "text": "<p><span style=\"font-size:12.0pt;\">Increasing pain</span></p>"
        },
        {
          "id": 382,
          "text": "<p><span style=\"font-size:12.0pt;\">Development of numbness in T8 dermatomal pattern</span></p>"
        },
        {
          "id": 383,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypopnea</span></p>"
        },
        {
          "id": 384,
          "text": "<p><span style=\"font-size:12.0pt;\">Perianal numbness</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An intradural mass lesion at the tip of a drug infusion catheter is LEAST likely to present as:</span></p>",
      "unique_key": "DT1227581",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>An intradural mass lesion (such as a granuloma) forming at the tip of a drug infusion catheter is <strong>least likely to present as hypopnea</strong>. Hypopnea, which is shallow or slow breathing, is a sign of <strong>respiratory depression</strong>. This typically occurs due to systemic opioid overdose or rostral spread of intrathecal opioid to the brainstem's respiratory centers.</p>\n<ul>\n<li><strong>Intradural mass lesions (granulomas)</strong> are a recognized complication of <strong>chronic intrathecal drug delivery systems</strong>.</li>\n<li>They are more frequently associated with <strong>high concentrations and doses of opioids</strong> (e.g., morphine &gt; 10 mg/day, hydromorphone &gt; 10 mg/day) and <strong>long-term therapy</strong> (typically &gt; 6 months).</li>\n<li><strong>Common Presentations of an Intradural Mass Lesion:</strong>\n<ul>\n<li><strong>Increasing pain</strong> (localized or radiating, often worsening despite treatment).<strong>(Option A ruled out)</strong></li>\n<li><strong>Loss of drug effect</strong> (where the pain is no longer controlled despite increasing doses), indicating catheter obstruction or impaired drug delivery.</li>\n<li><strong>New or worsening neurological deficits</strong> below the level of the lesion, such as:\n<ul>\n<li><strong>Paresthesias/numbness</strong> (e.g., in a specific dermatomal pattern like T8 or perianal).<strong>(Option B and C r)</strong></li>\n<li><strong>Motor weakness</strong>.</li>\n<li><strong>Bowel/bladder dysfunction</strong>.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Hypopnea/Respiratory Depression:</strong> This is a <strong>systemic opioid effect</strong>, typically indicative of overdose or rostral spread of the drug, <strong>not a direct symptom of a localized compressive mass lesion</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>Increasing pain (Option A):</strong> This is a <strong>very common presentation</strong>, as the mass compresses pain-sensitive neural structures, leading to worsening pain despite continued intrathecal drug delivery.</li>\n<li><strong>Development of numbness in T8 dermatomal pattern (Option B):</strong> This is a <strong>likely presentation</strong>. A granuloma at the T8 spinal level could compress the corresponding nerve root, causing sensory deficits (like numbness or tingling) in that specific dermatome.</li>\n<li><strong>Perianal numbness (Option D):</strong> This indicates a lesion affecting the sacral dermatomes (S2-S5), which is a <strong>possible neurological deficit</strong> if the mass is located at a lower spinal level or if there is ascending compression affecting these nerve roots.</li>\n</ul>",
      "correct_choice_id": 383,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 40,
      "choices": [
        {
          "id": 391,
          "text": "<p><span style=\"font-size:12.0pt;\">Duloxetine</span></p>"
        },
        {
          "id": 392,
          "text": "<p><span style=\"font-size:12.0pt;\">Mexiletine</span></p>"
        },
        {
          "id": 393,
          "text": "<p><span style=\"font-size:12.0pt;\">Gabapentin</span></p>"
        },
        {
          "id": 394,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Each of the following drugs has been used to treat neuropathic pain. Selective inhibition of serotonin and norepinephrine reuptake is the mechanism of which drug?</span></p>",
      "unique_key": "DT1227584",
      "question_audio": null,
      "question_video": null,
      "map_id": 1227584,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p><strong>Duloxetine</strong> is the drug among the options that acts primarily through the <strong>selective inhibition of serotonin and norepinephrine reuptake</strong>. This mechanism classifies it as a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI). By increasing the availability of serotonin and norepinephrine in the synaptic cleft, duloxetine enhances the activity of descending pain inhibitory pathways in the brain and spinal cord, thereby providing analgesia for neuropathic pain.</p>\n<ul>\n<li><strong>Neuropathic Pain:</strong> Pain caused by damage or disease affecting the somatosensory nervous system. It's often characterized by burning, shooting, tingling, or electric-shock sensations.</li>\n<li><strong>Pharmacological Approaches for Neuropathic Pain:</strong>\n<ul>\n<li><strong>Antidepressants:</strong>\n<ul>\n<li><strong>SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors):</strong>\n<ul>\n<li><strong>Duloxetine</strong> and Venlafaxine.</li>\n<li><strong>Mechanism:</strong> Inhibit reuptake of both serotonin and norepinephrine, enhancing descending pain modulation.</li>\n</ul>\n</li>\n<li><strong>TCAs (Tricyclic Antidepressants):</strong>\n<ul>\n<li>Amitriptyline, Nortriptyline, Desipramine.</li>\n<li><strong>Mechanism:</strong> Also inhibit serotonin and norepinephrine reuptake, but with broader receptor effects (anticholinergic, antihistaminic, alpha-adrenergic blockade), leading to more side effects.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Antiepileptic Drugs (AEDs) / Gabapentinoids:</strong>\n<ul>\n<li><strong>Gabapentin</strong> and Pregabalin.<strong> (Option C ruled out)</strong></li>\n<li><strong>Mechanism:</strong> Structural analogs of GABA, but do not bind to GABA receptors. They bind to the alpha-2-delta subunit of voltage-gated calcium channels, reducing neurotransmitter release.</li>\n</ul>\n</li>\n<li><strong>Sodium Channel Blockers:</strong>\n<ul>\n<li><strong>Mexiletine:</strong> An oral antiarrhythmic (Class Ib) and local anesthetic analog.<strong>(Option B ruled out)</strong></li>\n<li><strong>Mechanism:</strong> Blocks voltage-gated sodium channels, reducing neuronal excitability.</li>\n<li><strong>Indications:</strong> Can be used for neuropathic pain, but often as a third-line agent due to systemic side effects (cardiac, GI).</li>\n<li><strong>Carbamazepine:</strong> An anticonvulsant.<strong>(Option D ruled out)</strong></li>\n<li><strong>Mechanism:</strong> Stabilizes inactivated sodium channels.</li>\n<li><strong>Indications:</strong> <strong>First-line treatment for Trigeminal Neuralgia</strong>, also used for other neuropathic pain conditions.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Duloxetine</strong> (an SNRI) is the correct answer because it <strong>selectively inhibits serotonin and norepinephrine reuptake</strong>, a key mechanism for treating neuropathic pain.</li>\n<li>Remember the distinct mechanisms of action for other neuropathic pain drugs: <strong>Gabapentin</strong> (calcium channel modulation), <strong>Mexiletine</strong> and <strong>Carbamazepine</strong> (sodium channel blockade).</li>\n</ul>",
      "correct_choice_id": 391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}